Literature DB >> 15052665

Development of multiorgan pathology in the wpk rat model of polycystic kidney disease.

Vincent H Gattone1, Benjamin A Tourkow, Chad M Trambaugh, Alexander C Yu, Shelly Whelan, Carrie L Phillips, Peter C Harris, Richard G Peterson.   

Abstract

Rodent models of polycystic kidney disease (PKD) have provided valuable insight into the cellular changes associated with cystogenesis in humans. The present study characterizes the morphology of renal and extrarenal pathology of autosomal recessive PKD induced by the wpk gene in Wistar rats. In wpk(-/-) rats, proximal tubule and collecting duct cysts develop in utero and eventually consume the kidney. Increased apoptosis, mitosis, and extracellular tenascin deposition parallel cyst development. Extrarenal pathology occurs in the immune system (thymic and splenic hypoplasia) and central nervous system (CNS; hypoplasia to agenesis of the corpus callosum with severe hydrocephalus). Severity of hydrocephalus varied inversely with size of the corpus callosum. In wpk(-/-) rats, the corpus callosum exhibits relatively few axons that cross the midline. This CNS pathology is similar to that described in three human renal cystic syndromes: orofaciodigital, genitopatellar, and cerebrorenal-digital syndromes. Collecting duct and ventricular ependymal cilia appear morphologically normal. To determine if rodent background strain and the presence of modifier genes affect severity of the disease, we crossed the Wistar-wpk rat with Brown Norway (BN) and Long Evan (LE) rats and found the degree of renal and cerebral pathology was diminished as evidenced by lower kidney weight as a percent of body weight and serum urea nitrogen concentration in cystic rats on LE or BN strains as well as less prominent cranial enlargement. Crosses with BN rats allowed us to localize the wpk gene on chromosome 5 very close to the D5Rat73 marker. The wpk gene lies within a chromosomal region known to harbor a PKD modifier locus. In summary, the types of renal and cerebral pathology seen in the Wistar wpk rat are a unique combination seen only in this rodent model. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15052665     DOI: 10.1002/ar.a.20022

Source DB:  PubMed          Journal:  Anat Rec A Discov Mol Cell Evol Biol        ISSN: 1552-4884


  26 in total

1.  Inhibition of cyst growth in PCK and Wpk rat models of polycystic kidney disease with low doses of peroxisome proliferator-activated receptor γ agonists.

Authors:  Stephanie M Flaig; Vincent H Gattone; Bonnie L Blazer-Yost
Journal:  J Transl Int Med       Date:  2016-09-23

Review 2.  Senior-Løken syndrome: a syndromic form of retinal dystrophy associated with nephronophthisis.

Authors:  C C Ronquillo; P S Bernstein; W Baehr
Journal:  Vision Res       Date:  2012-07-20       Impact factor: 1.886

3.  Differential expression of renal proteins in a rodent model of Meckel syndrome.

Authors:  Stephen B Mason; Xianyin Lai; Heather N Ringham; Robert L Bacallao; Peter C Harris; Frank A Witzmann; Vincent H Gattone
Journal:  Nephron Exp Nephrol       Date:  2010-08-06

4.  The Meckel-Gruber syndrome gene, MKS3, is mutated in Joubert syndrome.

Authors:  Lekbir Baala; Stephane Romano; Rana Khaddour; Sophie Saunier; Ursula M Smith; Sophie Audollent; Catherine Ozilou; Laurence Faivre; Nicole Laurent; Bernard Foliguet; Arnold Munnich; Stanislas Lyonnet; Remi Salomon; Ferechte Encha-Razavi; Marie-Claire Gubler; Nathalie Boddaert; Pascale de Lonlay; Colin A Johnson; Michel Vekemans; Corinne Antignac; Tania Attie-Bitach
Journal:  Am J Hum Genet       Date:  2006-11-15       Impact factor: 11.025

5.  Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3.

Authors:  Rachaneekorn Tammachote; Cynthia J Hommerding; Rachel M Sinders; Caroline A Miller; Peter G Czarnecki; Amanda C Leightner; Jeffrey L Salisbury; Christopher J Ward; Vicente E Torres; Vincent H Gattone; Peter C Harris
Journal:  Hum Mol Genet       Date:  2009-06-10       Impact factor: 6.150

6.  A mouse model for Meckel syndrome type 3.

Authors:  Susan A Cook; Gayle B Collin; Roderick T Bronson; Jürgen K Naggert; Dong P Liu; Ellen C Akeson; Muriel T Davisson
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

7.  Variable expressivity of ciliopathy neurological phenotypes that encompass Meckel-Gruber syndrome and Joubert syndrome is caused by complex de-regulated ciliogenesis, Shh and Wnt signalling defects.

Authors:  Zakia A Abdelhamed; Gabrielle Wheway; Katarzyna Szymanska; Subaashini Natarajan; Carmel Toomes; Chris Inglehearn; Colin A Johnson
Journal:  Hum Mol Genet       Date:  2013-01-02       Impact factor: 6.150

8.  Meckel-Gruber syndrome protein MKS3 is required for endoplasmic reticulum-associated degradation of surfactant protein C.

Authors:  Mei Wang; James P Bridges; Cheng-Lun Na; Yan Xu; Timothy E Weaver
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

9.  The Meckel syndrome protein meckelin (TMEM67) is a key regulator of cilia function but is not required for tissue planar polarity.

Authors:  Amanda C Leightner; Cynthia J Hommerding; Ying Peng; Jeffrey L Salisbury; Vladimir G Gainullin; Peter G Czarnecki; Caroline R Sussman; Peter C Harris
Journal:  Hum Mol Genet       Date:  2013-02-07       Impact factor: 6.150

10.  MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert Syndrome.

Authors:  Meral Gunay-Aygun; Melissa A Parisi; Dan Doherty; Maya Tuchman; Ekaterini Tsilou; David E Kleiner; Marjan Huizing; Baris Turkbey; Peter Choyke; Lisa Guay-Woodford; Theo Heller; Katarzyna Szymanska; Colin A Johnson; Ian Glass; William A Gahl
Journal:  J Pediatr       Date:  2009-06-21       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.